DK1027895T3 - Erysipelothrix rhusiopathiae-antigener og vaccinepræparater - Google Patents
Erysipelothrix rhusiopathiae-antigener og vaccinepræparaterInfo
- Publication number
- DK1027895T3 DK1027895T3 DK99309202T DK99309202T DK1027895T3 DK 1027895 T3 DK1027895 T3 DK 1027895T3 DK 99309202 T DK99309202 T DK 99309202T DK 99309202 T DK99309202 T DK 99309202T DK 1027895 T3 DK1027895 T3 DK 1027895T3
- Authority
- DK
- Denmark
- Prior art keywords
- vaccine preparations
- erysipelothrix rhusiopathiae
- antigens
- rhusiopathiae antigens
- erysipelothrix
- Prior art date
Links
- 241000186810 Erysipelothrix rhusiopathiae Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11770499P | 1999-01-29 | 1999-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1027895T3 true DK1027895T3 (da) | 2008-06-09 |
Family
ID=22374369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99309202T DK1027895T3 (da) | 1999-01-29 | 1999-11-18 | Erysipelothrix rhusiopathiae-antigener og vaccinepræparater |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1027895B1 (da) |
| JP (3) | JP3535436B2 (da) |
| CN (1) | CN1210062C (da) |
| AR (1) | AR020022A1 (da) |
| AT (1) | ATE386540T1 (da) |
| AU (1) | AU776847B2 (da) |
| BR (1) | BR9905853B1 (da) |
| CA (1) | CA2290078C (da) |
| CY (1) | CY1107910T1 (da) |
| DE (1) | DE69938168T2 (da) |
| DK (1) | DK1027895T3 (da) |
| ES (1) | ES2301230T3 (da) |
| NZ (1) | NZ501128A (da) |
| PT (1) | PT1027895E (da) |
| TW (1) | TW546146B (da) |
| ZA (1) | ZA997138B (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8637047B2 (en) * | 2003-10-30 | 2014-01-28 | Boehringer Ingelheim Vetmedica, Inc. | Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same |
| CN107496913A (zh) * | 2017-09-15 | 2017-12-22 | 天津瑞普生物技术股份有限公司 | 猪丹毒、猪细小病毒、猪流感病毒三联灭活疫苗制备方法 |
| CN107648599A (zh) * | 2017-09-18 | 2018-02-02 | 天津瑞普生物技术股份有限公司 | 一种猪丹毒、猪细小病毒二联灭活疫苗的制备方法 |
| CN110812473A (zh) * | 2019-12-10 | 2020-02-21 | 广东君睿生物技术研究有限公司 | 一种副猪嗜血杆菌病、猪链球菌病和猪多杀性巴氏杆菌病三联灭活疫苗及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0294071A3 (en) * | 1987-06-03 | 1990-08-01 | Merck & Co. Inc. | Hepatitis b vaccines made with pre-formed aluminum hydroxide gels, and processes thereof |
| US5695769A (en) * | 1990-06-13 | 1997-12-09 | Pfizer Inc. | Pasteurella multocida toxoid vaccines |
| DK0669971T3 (da) * | 1991-11-15 | 2003-04-22 | Pfizer | Fremgangsmåde til fremstilling af Gram-negative bakterielle vacciner |
| US5690942A (en) * | 1995-06-02 | 1997-11-25 | American Home Products Corporation | Adjuvants for viral vaccines |
| JP3072345B1 (ja) * | 1999-03-31 | 2000-07-31 | 農林水産省家畜衛生試験場長 | 豚丹毒菌の組換えサブユニットワクチン |
-
1999
- 1999-11-16 AU AU59445/99A patent/AU776847B2/en not_active Expired
- 1999-11-16 NZ NZ501128A patent/NZ501128A/en not_active IP Right Cessation
- 1999-11-16 ZA ZA9907138A patent/ZA997138B/xx unknown
- 1999-11-16 CA CA2290078A patent/CA2290078C/en not_active Expired - Lifetime
- 1999-11-17 TW TW088120004A patent/TW546146B/zh not_active IP Right Cessation
- 1999-11-18 EP EP99309202A patent/EP1027895B1/en not_active Expired - Lifetime
- 1999-11-18 PT PT99309202T patent/PT1027895E/pt unknown
- 1999-11-18 DK DK99309202T patent/DK1027895T3/da active
- 1999-11-18 AT AT99309202T patent/ATE386540T1/de active
- 1999-11-18 ES ES99309202T patent/ES2301230T3/es not_active Expired - Lifetime
- 1999-11-18 DE DE69938168T patent/DE69938168T2/de not_active Expired - Lifetime
- 1999-12-15 CN CNB991261631A patent/CN1210062C/zh not_active Expired - Lifetime
- 1999-12-15 BR BRPI9905853-7A patent/BR9905853B1/pt not_active IP Right Cessation
- 1999-12-23 AR ARP990106727A patent/AR020022A1/es active IP Right Grant
-
2000
- 2000-01-24 JP JP2000017930A patent/JP3535436B2/ja not_active Expired - Lifetime
-
2002
- 2002-11-20 JP JP2002336512A patent/JP2003160507A/ja not_active Withdrawn
-
2007
- 2007-02-14 JP JP2007033458A patent/JP4714167B2/ja not_active Expired - Lifetime
-
2008
- 2008-03-20 CY CY20081100313T patent/CY1107910T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1210062C (zh) | 2005-07-13 |
| JP2003160507A (ja) | 2003-06-03 |
| EP1027895A3 (en) | 2001-07-18 |
| AU776847B2 (en) | 2004-09-23 |
| JP2000219637A (ja) | 2000-08-08 |
| PT1027895E (pt) | 2008-03-18 |
| BR9905853B1 (pt) | 2011-11-01 |
| JP4714167B2 (ja) | 2011-06-29 |
| DE69938168D1 (de) | 2008-04-03 |
| NZ501128A (en) | 2001-12-21 |
| BR9905853A (pt) | 2000-11-14 |
| JP2007119499A (ja) | 2007-05-17 |
| CA2290078C (en) | 2013-01-22 |
| DE69938168T2 (de) | 2009-02-26 |
| ZA997138B (en) | 2001-05-16 |
| EP1027895B1 (en) | 2008-02-20 |
| AR020022A1 (es) | 2002-03-27 |
| ES2301230T3 (es) | 2008-06-16 |
| CY1107910T1 (el) | 2013-09-04 |
| HK1029062A1 (en) | 2001-03-23 |
| CA2290078A1 (en) | 2000-07-29 |
| AU5944599A (en) | 2000-08-03 |
| CN1262129A (zh) | 2000-08-09 |
| EP1027895A2 (en) | 2000-08-16 |
| TW546146B (en) | 2003-08-11 |
| ATE386540T1 (de) | 2008-03-15 |
| JP3535436B2 (ja) | 2004-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2775601B1 (fr) | Vaccins vivants recombines et adjuves | |
| DK1210113T3 (da) | Kombinerede vaccinepræparater | |
| NL300311I2 (nl) | Adjuvanssytemen en vaccins | |
| CY2009014I2 (el) | Εμβολιο εναντι αντιγονων απο βακτηριδια | |
| DK0894135T3 (da) | Multivalent og multispecifikt antigenbindingsprotein | |
| NO20015888L (no) | Implanterbart gelpreparat og fremgangsmåter for fremstilling derav | |
| ATE345392T1 (de) | Genetisch manipulierter bleb impfstoff | |
| NO996133D0 (no) | Olje-i-vann-vaksinesammensetninger | |
| NO20032303D0 (no) | Frysetörket pantoprazol-preparat og pantoprazol-injeksjon | |
| DK2325317T3 (da) | Receptornukleinsyrer og polypeptidr | |
| DK1228217T3 (da) | Konserverede neisseria-antigener | |
| BR9711853A (pt) | Vacinas | |
| MA25489A1 (fr) | Vaccins | |
| EP1242049A4 (en) | VACCINE COMPOSITIONS AND ANTIGEN PEPTIDES ASSOCIATED WITH CLASS I HLA-A2 TUMOR | |
| DK1210112T3 (da) | Vaccine mod HBV og HPV | |
| DE60002650D1 (de) | Öladjuvierter Impfstoff | |
| NO2006005I2 (no) | Difteri-,tetanus-, acellulære kikhoste- og polioantigener | |
| EP1185545A4 (en) | CD4-INDEPENDENT HIV ENVELOPE PROTEINS FOR USE AS VACCINES AND THERAPEUTIC AGENTS | |
| AU5577201A (en) | Immunogenic pneumococcal protein and vaccine compositions thereof | |
| NO20016247D0 (no) | Streptograminderivater, deres fremstilling og preparater inneholdende derivatene | |
| DK1027895T3 (da) | Erysipelothrix rhusiopathiae-antigener og vaccinepræparater | |
| ATE519775T1 (de) | Rekombinante untereinheiten-impfstoffe | |
| EP1283717A4 (en) | RECOMBINANT LEUKOTOXIN VACCINE FROM FUSOBACTERIUM NECROPHORUM AND ITS PREPARATION | |
| DK1216021T3 (da) | Farmaceutiske og/eller kosmetiske præparater | |
| FR2802775B1 (fr) | Preparations glacees et aerees |